Influence of the cardiac cycle on pCASL: cardiac triggering of the end-of-labeling by unknown
1 3
Magn Reson Mater Phy
DOI 10.1007/s10334-017-0611-6
RESEARCH ARTICLE
Influence of the cardiac cycle on pCASL: cardiac triggering of the 
end‑of‑labeling
Jasper Verbree1 · Matthias J. P. van Osch1 
Received: 8 December 2016 / Revised: 25 January 2017 / Accepted: 13 February 2017 
© The Author(s) 2017. This article is published with open access at Springerlink.com
Keywords Perfusion magnetic resonance imaging · 
Cerebrovascular circulation · Pulsatile flow · Cerebral 
blood flow
Introduction
Pseudo continuous arterial spin labeling (pCASL) is the 
current recommended and validated non-invasive MR 
technique to image cerebral blood flow (CBF) [1, 2]. The 
pCASL sequence consists of separate label and control 
acquisitions which are subtracted to yield a CBF meas-
urement. Since labeling efficiency of pCASL depends 
on the blood flow velocity [3], and the recommended 
labeling duration is approximately two times the cardiac 
interval, perturbations of the ASL-signal due to variation 
in timing of the acquisitions with respect to the cardiac 
cycle should be expected. Such physiological noise could 
potentially be reduced by synchronizing the ASL acquisi-
tions to the cardiac cycle. Synchronizing the moment of 
labeling to the cardiac cycle by means of cardiac trigger-
ing has been shown to reduce signal variability over time 
in pulsed ASL [4, 5]. However, pulsed ASL has a much 
shorter labeling duration (≈20 ms) compared to pCASL 
(1500–2000 ms) and the generation of label is, therefore, 
almost instantaneous and can easily be timed to always 
happen at the same moment within the cardiac cycle. A 
similar cardiac triggering approach has previously been 
investigated in continuous ASL by triggering the start of 
the labeling. However, no improvements in signal stabil-
ity were observed using this approach [6]. This might be 
explained by the long labeling duration that will result in 
asynchronous timing at the end of the labeling and the 
moment of imaging even when the start of the labeling 
was triggered.
Abstract 
Objective In arterial spin labeling (ASL), the cardiac cycle 
might adversely influence signal-stability by varying the 
amount of label created, labeling efficiency and/or trans-
port times. Due to the long labeling duration in pseudo-
Continuous ASL (pCASL), the blood labeled last contrib-
utes most to the ASLsignal. The present study investigated, 
using numerical simulations and in vivo experiments, the 
effect of the cardiac cycle on pCASL, thereby focusing on 
the end-of-labeling.
Materials and methods In the in vivo experiments the end-
of-labeling was timed to a specific cardiac phase while a 
long labeling duration of >7 s was used to isolate the influ-
ence of the lastly labeled spins on ASL-signal stability.
Results Simulations showed dependence of the ASL-signal 
on the cardiac phase of the end-of-labeling, and that the 
variation in signal was more pronounced at lower heart 
rates. The ASL-signal variation was small (~4%), but could 
be effectively reduced by simulated end-of-labeling trigger-
ing. In vivo, no difference in mean CBF (p = 0.58) nor in 
CBF temporal-STD (p = 0.44) could be detected between 
triggered and non-triggered acquisitions.
Conclusion Influence of the cardiac cycle on pCASL-
signal stability is small and triggering the start-of-labeling 
and end-of-labeling can be considered not to have practical 
implications to improve stability.
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In ASL, the magnetic labeling of blood decays 
with the T1 of arterial blood (at least until the label is 
exchanged with brain tissue after which it will decay 
with the T1 of tissue). Label generated later in the 
labeling period will be less affected by this decay and 
will, therefore, contribute more to the detected signal. 
For example, at a labeling duration of 1.8 s, label gen-
erated at the end of the labeling period contributes a 
factor of three more to the totally detected ASL-signal 
compared to label generated at the start of labeling. 
Therefore, the largest contribution to the ASL-signal 
arises from the end of the labeling period. The great-
est impact of cardiac triggering on ASL-signal stabil-
ity should, therefore, be expected when triggering the 
end-of-labeling.
Three main effects of flow velocity in the feeding 
arteries on pCASL signal stability can be expected. 
First, the amount of label generated is proportional to 
the volume of spins flowing through the labeling plane 
and, thus, on the blood flow velocity. Secondly, the 
labeling efficiency is known to depend on the veloc-
ity of the flowing blood. Finally, the transport time of 
label to the brain tissue is dependent on the blood flow 
velocity and will influence the relative time the label 
spends in the blood versus the tissue compartment. 
That is, faster delivery (i.e., higher flow velocity) of 
the label to the tissue will reduce the ASL-signal due 
to smaller T1 in tissue compared to the blood compart-
ment. Therefore, in summary, both the generation and 
the delivery of the label are dependent on the blood 
flow velocity, which varies over the cardiac cycle. 
Both effects could have an independent, but opposite 
influence on the pCASL-signal stability. Furthermore, 
these effects are expected to have a stronger impact on 
the ASL-signal at the end-of-labeling than at the start 
of the labeling.
The aim of the present study was to investigate the 
influence of the cardiac cycle on the pCASL-signal by 
studying the influence of triggering the end-of-labeling 
on the pCASL-signal stability. By focusing on the end-
of-labeling, the moment of the largest influence is iso-
lated, thereby providing a worst-case scenario estimation 
of the influence of the cardiac cycle on the pCASL-sig-
nal and its stability. Simulations were used to assess the 
influence of pulsatile flow in combination with varia-
tions in heart rate on the pCASL-signal stability. Sub-
sequently, in vivo experiments with end-of-labeling 
triggering were performed in normal healthy subjects 
to confirm the findings from these simulations. During 
the in vivo experiments impractically long labeling dura-
tions were employed to isolate the effect of triggering 
the end-of-labeling without confounding influences of 
variation in the total labeling duration.
Materials and methods
Numerical model
A numerical model was implemented in MATLAB 2016a 
(Mathworks, Natick, MA, USA) to investigate the effect 
of the cardiac cycle on the ASL-signal, by simulating 
both label generation and label delivery. The model was 
subsequently used to investigate the effect of pulsatile 
flow, heart rate variability and end-of-labeling triggering.
The numerical model simulates the label generation in 
a single artery and the delivery of the labeled spins into 
a large tissue compartment, which acts as a sink. Fresh 
blood flows into the artery at the labeling plane according 
to a typical velocity curve as encountered in the internal 
carotid artery of an adult person (see Fig. 1). The arte-
rial compartment consists of a single 300 mm long artery 
discretized into blocks of 0.01 mm length. Blood flow is 
simulated by shifting blocks, so that for blood flowing at 
24 cm/s at transport time through the arterial compart-
ment of 1250 ms is achieved. Labeling of blood is simu-
lated by introducing blocks with inverted magnetization, 
while taking into account the labeling efficiency (0.85). 
When no labeling is applied, the blood magnetization is 
set to the fully relaxed magnetization (M0 = 1.0). Each 
iteration (1 ms) the blood is pushed into the artery. Blood 
at the end of the artery is subsequently pushed into the 
tissue compartment, which has a size equal to 250,000 
blocks. Subsequently, the longitudinal (T1) magnetization 
of all blocks in the arterial and tissue compartments is 
updated according to the Bloch equations [7]:
where the time-step (dt) is taken as 1 ms and the T1 is set 
to T1,blood (1664 ms [8]) and T1,tissue (1105 ms, estimate 
Mz(t + dt) = Mz(t) · e

































Fig. 1  Graphical representation of a a typical velocity curve from 
a representative subject of the present study in the internal carotid 
artery, which is used as a template in the simulations and b the veloc-
ity dependent labeling efficiency as employed in the simulations. The 
labeling efficiency (dashed line) is adapted from the numerical model 
described in [10], while assuming a parabolic flow profile in the sim-
ulated artery (blue line). The dotted line denotes the average velocity 
(24 cm/s) for visual reference
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for a voxel containing both gray and white matter [9]) for 
the arterial  and tissue compartments, respectively.
The control condition of the ASL experiment is not 
explicitly simulated, but is assumed to be equal to the total 
sum of blocks making up the tissue compartment. This 
implies that we assume that the inflowing magnetization is 
only affected during the label condition and that the con-
trol condition is perfect and unaffected by the timing with 
respect to the cardiac cycle. The blood flow is calculated 
from the difference (ΔM) between the control condi-
tion and simulated label signal and subsequently quanti-
fied according to the consensus formula by correcting for 
the finite labeling duration (LBL) and post labeling delay 
(PLD) [1]:
The flow, or CBF, is the parameter of interest of the 
simulation and will be referred to as “signal” or “ASL-
signal” throughout the manuscript. The recommended tim-
ing of 1800 ms for labeling and PLD are used in the initial 
simulations.
Pulsatile blood flow is simulated by repeating the typical 
velocity curve (Fig. 1) to fill the entire duration of the sim-
ulation. To isolate the effect of flow pulsatility during labe-
ling (or the PLD), the velocity is set, for some experiments, 
equal to the mean velocity (i.e., constant velocity, no pul-
satility) during certain sub-parts of the ASL sequence. The 
heart rate was modified by altering the duration of the car-
diac cycle, i.e., by linearly scaling the flow velocity curve 
in the temporal domain. Heart rate variability is achieved 
in the same way, by randomly altering the duration of each 
cardiac cycle. Note that the pulsatility (difference between 
minimum and maximum velocity) is not altered throughout 
the simulations. The timing of the arrival of label in the tis-
sue compartment is characterized by the bolus arrival time 
(BAT) and the tail arrival time (TAT). BAT is defined as the 
first non-zero ASL-signal value arriving in the tissue com-
partment, whereas TAT is defined as the last non-zero ASL-
signal value leaving the arterial compartment.
Labeling efficiency is velocity-dependent and varies 
between the cardiac phases. The labeling efficiency for a 
single velocity has been described in a numerical model 
[10]. However, the flow profile within the vessel varies with 
the distance from the vessel wall. The data from the numer-
ical model [10] was recalculated assuming parabolic flow 
profile in the simulated artery (see Fig. 1b). To isolate the 
effects of spatially as well as temporally varying labeling 
efficiencies due to blood velocity differences from other 
influences on ASL signal stability, labeling efficiency was 
assumed constant for the other simulations.
The resulting ASL-signal and other variables (e.g., 
BAT) are expressed relative to the signal as obtained 
f = �M
ePLD/T1,blood
(1− e - LBL/T1,blood)
from simulations with a constant mean flow veloc-
ity as input. The relative signal (ΔS) is expressed as: 
ΔS = (B − A)/A × 100%, where A represents the con-
stant and B is the pulsatile flow condition. The cardiac 
phase is defined as the normalized timing within the car-
diac cycle and runs, therefore, from 0 to 1. Mean and 
standard deviations of the cardiac phase are calculated by 
taking into account that the cardiac phase “wraps around” 
each cardiac cycle, i.e., circular statistics [11].
In vivo experiments
Data from eight healthy volunteers (four female) with a 
mean age of 30 years (range 23–52), were acquired on 
a Philips 3T MRI (Achieva, Philips, Best, The Neth-
erlands). All participants were screened for MRI safety 
compliance, and the study protocol was approved by the 
Ethics Review Board of the Leiden University Medical 
Center. Prior written informed consent was obtained from 
all subjects, and the study was performed in accordance 
with the Helsinki protocol.
The vendor-supplied pCASL sequence was modi-
fied to incorporate both start-of-labeling as well as end-
of-labeling triggering. A graphical representation of the 
ASL sequence in relation to the trigger and the employed 
trigger-delays is depicted in Fig. 2. To stop the end-of-
labeling in a certain cardiac phase, a delay parameter was 
set on the scanner that determines the additional labeling 
duration after receiving a cardiac trigger event. The delay 
parameter was set by the operator to three distinct car-
diac phases (a–c) based upon the subject’s velocity curve, 
see Fig. 1. The velocity curve was obtained prior to the 















Fig. 2  Schematic representation of the modified pCASL sequence 
(top) with respect to the labeling RF, finger pulse-oxymetry signal 
(PPU) and blood flow velocity at the labeling plane. “Labeling” indi-
cates the minimum labeling duration (7500 ms—delay). Arrows indi-
cate the cardiac trigger and moment of end-of-labeling. Note the shift 
between finger PPU trigger and velocity during labeling
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acquisition parameters, see Table 1). The minimum labe-
ling duration, i.e., the moment after which the scanner 
will look for the next cardiac trigger, was chosen so that 
the expected average labeling duration was 7500 ms.
The triggered scan was acquired continuously, cycling 
through the cardiac phases (a–b–c–a–b–c…) resulting in 
20 label and control images for each cardiac phase. In 
addition to end-of-labeling triggering, both control and 
label acquisitions were triggered at the start-of-labeling 
to exclude any residual influence of the start-of-labeling. 
The control condition was defined to have the same labe-
ling duration as the preceding, end-of-labeling triggered 
label acquisition, this to ensure equal effects on static 
tissue magnetization for the control and label condition. 
A non-triggered reference ASL scan was acquired with 
the same imaging parameters and a labeling duration of 
7500 ms. Total scan time was approximately 1 h, exact 
duration depending on the heart rate.
The post-processing of the in vivo data were performed in 
MATLAB v2016a (Natick, MA, US) with the SPM12 tool-
box. After motion correction, the ASL-images were quantified 
using the consensus formula, taking into account the increase 
in PLD for later acquired slices (36 ms inter-slice interval with 
ascending slice-order, starting from 1800 ms) [1]:
The quantification was performed per dynamic to correct 
for the varying labeling duration while triggering the end-
of-labeling. The global scaling factor M0 was obtained from 
the maximum “pure water” CSF signal (M0,csf) in the lateral 
CBF =
6000 ·  · e
PLD
T1,blood








ventricles of the non-triggered scan assuming a fully relaxed 
signal at a repetition time of 8.2 s. The M0,csf was corrected 
for the water content of arterial blood (76%) to obtain the 
value of fully relaxed spin in blood: M0,blood = M0,csf × 0.76 
[12]. The average quantified CBF was subsequently calcu-
lated by employing a gray matter mask obtained from the 
segmentation of the T1-weighed scan. Differences between 
the (non-)triggered conditions were assessed using the non-
parametric Friedman’s test (Matlab 2016a).
Results
Simulations: constant flow
The ASL-signal evolution in the tissue compartment is 
depicted in Fig. 3 for three constant flow conditions. 
Increased flow rate during the PLD (while flow during 
labeling remained constant) caused the tail of the labeled 
blood (bolus) to arrive earlier in the tissue compartment. 
The lower T1 in the tissue compartment with respect to 
the blood compartment increased the rate of signal decay. 
Therefore, a higher flow rate during the PLD resulted in 
less detected ASL-signal (see inset, Fig. 3a).
Changing the flow only during labeling had two effects 
(see Fig. 3b): first, the ASL-signal increased with the higher 
flow rate as expected, i.e., more spins are labeled; secondly, 
the bolus arrival time (BAT) became the shorter (horizontal 
axis, Fig. 3b). The second effect also leads to faster decay 
of the ASL-signal similar to the results for increased flow 
velocity during the PLD due to the shorter T1 of tissue. 
Comparing the signal intensity in the insets of Fig. 3, it 
Table 1  Acquisition parameters
TFE Turbo Field Techo, Venc phase-encoding velocity, SENSE parallel imaging technique
Anatomical T1-weighted Phase contrast MRA Triggered pCASL Non-triggered pCASL
Scan technique 3D Fast field echo 2-D Fast field echo Multi-slice gradient echo Multi-slice gradient echo
Acceleration type TFE factor 179, SENSE 
1.8 RL
– SENSE factor 2.5, EPI 
factor 35
SENSE factor 2.5, EPI 
factor 35
Repetition time/echo time 9.8/4.6 ms 13/8 ms Variable/14 ms 8200 ms (fixed)/14 ms
Flip/refocusing angle 8°/– 10°/– 90°/– 90°/–
Field of view 224 × 176 × 168 mm3 150 × 103 × 6 mm3 240 × 240 × 119 mm3 240 × 240 × 119 mm3
Acquisition voxel size 1.19 × 1.21 × 1.20 mm3 1.17 × 1.17 × 6.00 mm3 3 × 3 × 7 mm3 3 × 3 × 7 mm3
Acquisition matrix 188 × 146 128 × 128 80 × 80 80 × 80
Scan duration 2:47 min 2.5 − 4 min Variable 7 min
Labeling duration – – 7000 ms (minimum) 7500 ms (fixed)
Post labeling duration – – 1800 ms 1800 ms
Additional parameters Inversion delay 935 ms Venc 200 cm/s; 2 averages; 
retrospective triggering; 
15 cardiac phases
Set trigger delay 
(0 − 1000 ms)
–
TFE dur. shot/acq  1938/1757 ms
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can be appreciated that the first (i.e., flow) effect dominates 
over the compartmental T1-effect. Finally, increased flow 
during both labeling and PLD overlays previous effects 
(see Fig. 3c).
Simulations: pulsatile flow
The effect of pulsatile flow on the signal inflow in the tis-
sue compartment is depicted in Fig. 4. The labeling dura-
tion (1800 ms) was set exactly equal to two cardiac cycles 
(R–R interval 900 ms) and the velocity of blood during the 
PLD was set to the average velocity over one cardiac cycle. 
Therefore, the volume of blood that is labeled was constant 
for each simulation and, thus, independent of the cardiac 
phase of the start-of-labeling.
The pulsatile flow can be seen to influence the ASL-sig-
nal relative to the simulation with constant flow (Fig. 4a), 
even while the volume of label created was equal and con-
stant. Therefore, differences in the exact timings when label 
is created (start- versus the end of the labeling) appear to 
influence the detected signal even after accounting for loss 
of label due to longitudinal relaxation. Changes in the bolus 
arrival time (Fig. 4b) illustrate the variation in timing of 
label delivery and the influence of compartmental T1 differ-
ences. Setting the same T1 for both compartments resulted 
in a very similar signal profile (Fig. 4a, yellow curve). 
Finally, adding pulsatile flow during the PLD (Fig. 4a, red 
curve) resulted in a slightly stronger influence on the tim-
ing of delivery (i.e., of the bolus tail), which induced only 



























Fig. 3  Simulated ASL-signal evolution in the tissue compartment 
(top panels) during constant flow. Constant velocity increase/decrease 
during: a PLD only; b labeling only; and c both labeling and PLD. 
The insets show a close-up of the signals at the moment of imaging 
(same scale for all insets)
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Fig. 4  Simulated pulsatile flow of two cardiac cycles during labe-
ling (R–R interval 900 ms = 67 bpm). a ASL-signal of pulsatile flow 
during label only (yellow), label only and equal T1 for blood and tis-
sue compartments (blue) and pulsatile flow during labeling and PLD 
(red). d Bolus arrival time (BAT). BAT curve was equal for all three 
conditions; therefore, a single curve is shown. All signals are normal-
ized to the constant flow condition and aligned to the cardiac phase at 
the end-of-labeling
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Simulations: heart rate
In normal physiological conditions the heart rate will not 
exactly match the labeling duration and, consequently, the 
volume of labeled blood will vary, depending on the car-
diac phase of the start- and, thus, also the end-of-labeling. 
Multiple fixed heart rates between 40 and 90 bpm were 
simulated ,and the phase of the start-of-labeling was varied 
to cover the entire cardiac cycle. First, the effect of pulsa-
tile flow during labeling was investigated (while flow was 
constant during the PLD).
The volume of labeled spins (i.e., the number of spins 
labeled, which should not be confused with the detected 
ASL-signal at which point the label will have decayed 
considerably) can be seen to depend on the cardiac phase 
when labeling stopped (Fig. 5a) [except for the case when 
labeling equals exactly two cardiac cycles when the labeled 
volume was, again, constant (Fig. 5a, 67 bpm yellow)]. The 
relative signal variation over the cardiac cycle (min–max 
range) was notably higher at lower heart rates (Fig. 5b). 
Although visually there is a strong resemblance between 
the shape of labeled volume and the ASL-signal, the special 
case of constant labeling volume (Fig. 5a, 67 bpm yellow) 
illustrates that there is a similar amount of signal variation 
even when there is no variation in labeled volume. Moreo-
ver, the curves in Fig. 5b are all synchronized with respect 
to the end of-labeling, whereas after sorting them versus 
the start of labeling (Fig. 5d) this coherence is lost. There-
fore, the signal variation in Fig. 5b shows an effect of the 
end-of-labeling rather than an effect of labeled volume or 
start-of-labeling.
The effect of pulsatile flow during the PLD (while keep-
ing flow constant during labeling) on the relative signal 
showed a very similar pattern as the relative signal due 
to pulsatile flow during labeling (compare Fig. 5a–c with 
Fig. 5e–g). The effect of label generation and delivery will, 
therefore, reinforce each other, independent of heart rate.
Simulations: labeling efficiency
Until this moment labeling efficiency was assumed con-
stant over the cardiac cycle;, however, it is known to be 
dependent on the velocity of the blood [10, 13]. Veloc-
ity-dependent labeling efficiency (Fig. 1) was, therefore, 
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Fig. 5  Simulated multiple heart rates with pulsatile flow during labe-
ling and PLD. a–d Pulsatile flow during labeling, while PLD flow 
was constant. The special condition of exactly two cardiac cycles in 
the labeling period is shown in yellow (67 bpm), i.e., the situation of 
Fig. 4. e–g Simulation of fixed heart rates with pulsatile flow rate dur-
ing PLD only. Flow during labeling was constant. TAT: tail arrival 
time of the bolus, with a positive value meaning later arrival in tis-
sue compartment. d Same relative signal as in b, only then aligned 
to the start of the labeling. All values are normalized to the constant 
flow condition. h Difference in simulated relative signal between con-
stant and velocity dependent labeling efficiency. Difference values are 
expressed in percentage points
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added to the simulations with pulsatile flow during labe-
ling and PLD. Similar curves were obtained as with con-
stant labeling efficiency: the difference between constant 
and velocity dependent labeling efficiency was only 
−0.35 ± 0.08 percentage point (95%-confidence inter-
val: −0.37, −0.33%), as shown graphically in Fig. 5h. 
The influence of labeling efficiency was more pro-
nounced at higher heart rates.
Simulations: labeling duration
At a very long labeling duration of 7 s, increasing the 
labeling duration by 1 s had no effect on the relative sig-
nal within the precision of the simulation (Fig. 6a). As 
the cardiac phase of end-of-labeling shifts with increas-
ing labeling duration, the BAT can be seen to shift as 
well (Fig. 6b). The relative labeled volume increases 
with labeling duration as expected (Fig. 6c).
Simulations: triggering the end‑of‑labeling
The bridge to the in vivo experiments was made by sim-
ulating the end-of-labeling triggering using the same 
parameters as during the in vivo experiments. After labe-
ling for minimally 7 s, labeling was continued for an 
additional labeling period after a trigger; this was dubbed 
“trigger delay” (see “In-vivo experiment methods” section 
for details). The normal physiological situation was simu-
lated by adding heart rate variability (HRV) to the cardiac 
cycle. For this simulation, a pulsatile flow profile with a 
HRV of 100 ms was generated at two mean heart rates of 
40 and 90 bpm as two extreme cases. Due to the stochas-
tic nature of the HRV, each trigger-delay was simulated 
33 times. The start-of-labeling was also triggered simi-
larly as done in the in vivo experiment. The non-triggered 
case was simulated 33 times with a mean labeling dura-
tion of 7500 ms.
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Fig. 6  Simulated effect of additional labeling duration on: a rela-
tive ASL-signal; b bolus arrival time and c labeled volume. Pulsatile 
flow was simulated during labeling and PLD at a fixed heart rate of 
50 bpm. All values are normalized to the constant flow condition with 
a labeling duration of 7000 ms
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Fig. 7  Simulated end-of-labeling triggering at an average heart rate 
of 40 bpm (blue) and 90 bpm (red) with a heart rate variability of 
100 ms. a Relative ASL-signal with triggering. b Relative ASL-sig-
nal without triggering (random selection of 33 data points from a). c 
Standard deviation of data in a. All values are normalized to the con-
stant flow condition. Error bars indicate the standard deviation
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From Fig. 7a it can be appreciated that HRV introduces 
uncertainty in the determination of the exact phase of the 
end-of-labeling (i.e., variation in the x axis). A similar pat-
tern in relative ASL-signal as in Fig. 5b can be observed. 
As the variation in ASL-signal due to labeled volume is 
negligible at these long labeling durations, this is mostly 
the effect of the end-of-labeling phase. The variation in sig-
nal is, again, more pronounced at the lower heart rate both 
for the triggered (Fig. 7a) as well as for the non-triggered 
(Fig. 7b) case. The standard deviation of the non-triggered 
ASL-signal averaged over the cardiac cycle was 4.7 and 
2.0%, for 40 and 90 bpm, respectively (see Fig. 7b). The 
standard deviations along the y axis in Fig. 7a were plotted 
separately in Fig. 7c. A strong reduction in standard devia-
tion can be observed at any end-of-labeling phase when 
triggering (see Fig. 7c) compared to the non-triggered (see 
Fig. 7b).
In vivo experiments
Physiological parameters as measured during the in vivo 
triggered and non-triggered scans are provided in Table 2. 
Heart rate (p = 0.31) and mean (p = 0.65) and standard 
deviation (p = 0.63) of the labeling duration did not dif-
fer significantly between scans or trigger condition. When 
comparing the phase in the cardiac cycle that we aimed for 
by setting the post-trigger delay with the actual phase at the 
end-of-labeling, a close correspondence is found (Table 2). 
The combination of triggering and set delay showed little 
variation around the intended cardiac phase [5% at longest 
tested delay (c)].
The mean gray matter CBF was 55.34 ± 21.21, 
53.81 ± 18.85 and 55.80 ± 18.78 ml/100 g/min for the trig-
gered conditions a,b, and c and 54.19 ± 19.37 ml/100 g/
min for the non-triggered scan. No difference in mean CBF 
between the four conditions could be detected (p = 0.58, 
Friedman’s test), see Fig. 8a. The temporal standard devia-
tion of the CBF (13.59 ± 5.04, 14.79 ± 4.23, 15.60 ± 5.38 
and 15.04 ± 6.31 ml/100 g/min) was comparable between 
the four conditions (p = 0.44), see Fig. 8b.
Discussion
The present study investigated the effect of the cardiac 
cycle on pCASL and especially focused on the effect of 
end-of-labeling triggering on ASL-signal stability. Simu-
lations showed a clear, although small (on the order of 
4% of the ASL-signal) influence of flow pulsations on 
the ASL-signal, even when the labeling duration spanned 
multiple cardiac cycles. The timing of the pulsatile flow 
was shown to influence both the generation- and deliv-
ery of the label, and the resulting effect on the ASL-sig-
nal was most associated with the end-of-labeling phase. 
However, the in vivo experiments could not detect a dif-
ference in mean ASL-signal or temporal ASL-signal sta-
bility between the cardiac phases of the end-of-labeling 
triggering and/or with the non-triggered scan.
This study aimed to investigate the influence of the 
cardiac cycle on pCASL measurements of CBF, par-
ticularly during the end-of-labeling, since that timing 
will affect the ASL-signal stability most. To isolate the 
influence of cardiac cycle during the end-of-triggering 
on ASL-signal stability, an impractical long labeling 
duration was employed and combined with end-of-labe-
ling triggering: by using these very long labeling dura-
tions (>7 s) in the in vivo experiment, the occurrence of 
additional labeling of, e.g., 1 s had little influence on the 
overall signal as was confirmed by the simulations (see 
Fig. 6). When translating this to practical scan proper-
ties, triggering the end-of-labeling could be a candidate 
approach to minimize signal instabilities due to the car-
diac cycle, although it might introduce more unwanted 
effects than solving when employed with commonly 
employed labeling durations. For instance, at a typical 
heart rate of 60 bpm, the additional labeling duration 
Table 2  Physiological values 
for the in vivo experiment
Values are mean ± std. tSTD is the temporal standard deviation over 20 dynamics. p value indicates the 
repeated-measures ANOVA comparison between the four conditions
(a) (b) (c) NT p value
Heart rate (bpm) 59 ± 8 59 ± 8 59 ± 8 62 ± 11 0.08
Label duration (ms) 7517 ± 97 7492 ± 140 7475 ± 123 7455 ± 7 0.65
Label duration tSTD (ms) 311 ± 95 284 ± 66 324 ± 74 0.63
Set delay (ms) 70 ± 0 418 ± 78 576 ± 82
Cardiac phase (0–1)
 End-of-labeling 0.07 ± 0.01 0.40 ± 0.06 0.55 ± 0.07 0.70 ± 0.20
 End-of-labeling tSTD 0.01 ± 0.00 0.03 ± 0.01 0.05 ± 0.02 0.20 ± 0.01
 Imaging 0.71 ± 0.19 0.03 ± 0.21 0.83 ± 0.22 0.68 ± 0.17 0.78
 Imaging tSTD 0.11 ± 0.02 0.13 ± 0.02 0.14 ± 0.03 0.20 ± 0.01 0.54
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could vary up to 1 s; therefore, the ASL-signal change 
due to the volume of additionally generated label at 
2.8 s compared to 1.8 s labeling, could overshadow the 
potential effect of increased signal stability due to end-
of-labeling triggering, while greatly complicating the 
consistency of CBF quantification. To provide equal 
quantitative CBF-estimation over such a wide range of 
labeling durations, it would be crucial to have an accu-
rate estimate of dispersion of the bolus of labeled spins 
[4] and the exact exchange time of the label from the 
intra- to the extravascular compartment [14], which are 
both difficult to estimate in an individual subject. There-
fore, the present study aimed first to study how large the 
effect of the cardiac cycle is on the signal stability, focus-
ing thereby on the potential benefit and properties of end-
of-labeling triggering before moving on to solving all the 
implementation issues that would be encountered when 
using such an approach in practical clinical applications. 
The simulation and in vivo results suggest; however, that 
implementing end-of-labeling triggering does not pro-
vide important improvements in signal stability for most 
pCASL applications. Therefore, it was not deemed useful 
to solve the aforementioned implementation challenges. 
It should be noted that during the in vivo experiments, 
only the label condition was end-of-labeling triggered, 
whereas the following control condition was acquired 
with the same ‘labeling’ duration. Hence, the repetition 
time (TR) was the same for each label and control pair, 
thereby avoiding that magnetization differences would 
affect pair-wise subtractions. Even when controlling for 
these confounding effects, no improvement in signal sta-
bility could be proven in the present in vivo study when 
using end-of-labeling triggering.
The simulations in the present study showed that signal 
fluctuations due to cardiac pulsations range between −8 
and +5%. Previous work with simulations of continuous 
ASL showed a similar ±5% range in signal variation for 
a labeling duration of 1500 ms (see Fig. 7 of Ref. [4]). 
However, their simulations (convolution of the velocity 
curve with the Buxton model) only took the effects into 
account that occurred while generating the label. Variation 
in the transport time of the label due to the cardiac cycle 
was not part of that continuous ASL study, although it was 
included in other studies, which investigated pulsed ASL 
[5, 15–17]. Both modeling and in vivo pulsed ASL data 
showed earlier arrival of the label with the systolic phase 
compared to the diastolic phase [5, 15–17]. The simula-
tions of the present study extend this concept to pCASL 
and showed that the delivery of label enhanced the sig-
nal fluctuations of labeling generation. In other words, 
the changes in transport times during the PLD due to 
cardiac fluctuations augment the ASL-signal increases 
and decreases caused by flow pulsations during labeling. 
Hence, the range in signal variations of the present simu-
lations is slightly larger than earlier predicted in literature. 
Moreover, this study is the first to show that these signal 
fluctuations are largely dependent on the phase of end-
of-labeling and not with the start-of-labeling. Finally, the 
influence of the cardiac cycle on the ASL-signal due to the 
changed transport times and the differences in the amount 
of generated label, were both greater than changes due to 
the velocity dependency of the labeling efficiency, which 
is often cited as a major concern in pCASL.
In the simulations we quoted the influence of the car-
diac cycle on ASL-signal by stating the observed signal 
range (−8 to +5%) to illustrate the maximum range of 







































Fig. 8  In-vivo measurements of mean gray matter CBF and tSTD 
of the triggered and non-triggered scans. tSTD is the temporal stand-
ard deviation over 20 dynamics. The moment of end-of-labeling in 
the cardiac cycle a–c was defined by a set delay and cardiac trig-
gering of the end-of-labeling. The cardiac phase of end-of-labeling 
varied randomly during the non-triggered scan (NT). Removing 
the potential outlier (green triangles) reduced the mean CBF to 
48.5 ± 8.4 ml/100 g/min, without effect on statistical inferences
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expected ASL-signal intensities; however, it could also 
have been expressed as temporal (tSTD), which has 
the advantage that it can be measured reliably in vivo. 
The tSTD of the simulated untriggered case was 4% at 
the lowest heart rate, which in the simulations reduced 
to 0.08% tSTD when end-of-labeling triggering was 
employed. The relative small effect of 4% shows that 
influence of the cardiac cycle is probably only a minor 
factor of observed ASL-signal fluctuations. Therefore, 
other physiological factors, such as respiration, might 
play a bigger role in pCASL [6, 18].
In the present study, the average coefficient of variation 
measured in the non-triggered scan coefficient of varia-
tion was 28 ± 11%, and; therefore, the number of subjects 
in the present study can be considered to be too small to 
be able to show a 4% difference in temporal STD. How-
ever, the number of participants was chosen on the abil-
ity to prove significant impact on single subject pCASL 
experiments. When the effect of end-of-triggering could 
not be proven in a group of eight subjects, it is clear that 
the total effect of cardiac pulsations can be considered 
minor in pCASL. Taken together, the simulations and 
in vivo experiments suggest that the effect of cardiac pul-
sations is small and triggering the end-of-labeling (and 
therefore also the start-of-triggering) provides no consist-
ent improvement in ASL-signal stability on a per-subject 
basis.
Other methods, besides cardiac triggering, have also 
been proposed to reduce noise in ASL. Background sup-
pression pulses have been shown to improve the general 
ASL-signal stability independent of cardiac pulsations 
[6]. Background suppression is particularly effective when 
using a read-out option with a single excitation pulse such 
as 3D-GRACE or 3D FSE stack-of-spirals [1]. Application 
of background suppression in the present study was not 
included, because of the high implementation complexity 
due to the varying TR of each label-control pair. Physio-
logical noise reduction can also be achieved during post-
processing, for example, by using RETROICOR [6, 18]. 
By design, RETROICOR includes the cardiac and respira-
tory regressor determined at the moment of imaging into 
account, whereas the influence of the cardiac cycle at the 
start-of-labeling or end-of-labeling was not considered [4, 
6, 18]. Application of RETROICOR in the present study 
proved to be of limited value due to the low number of 
dynamics for each condition (20 label-control pairs) and 
was, therefore, omitted from the final analysis. Although 
these post-processing techniques provide a consistent way 
to reduce (physiological) noise from ASL, it would be ben-
eficial when these noise-sources would be suppressed dur-
ing the acquisition of the signal. As an extreme variant of 
triggered ASL, we considered and tested “triple triggered” 
pCASL (triggering the start- and the end-of-labeling as 
well as the moment of imaging), which would appear to be 
more in line with physiology than the independent chosen 
values as currently employed. Triple triggered ASL leads, 
however, to ASL-signals that are mainly proportional to the 
duration cardiac cycle, and should, therefore, be considered 
to be not very informative.
The present study modeled the arterial compartment as 
a rigid vessel without compliance. Arterial compliance is 
an important mechanical property that gradually reduces 
the flow pulsatility along the arterial tree toward the tis-
sue compartment. Generation of label at the proximal end 
of the artery is governed by the typical flow curve (Fig. 1), 
which already included the compliance of the arterial tree. 
The delivery of the label to the tissue was shown in the 
present study to play a minor role compared to genera-
tion. Compliance decreases the flow pulsatility during the 
delivery phase, which would in turn reduce variations in 
delivery time and, thus, increase overall signal variability. 
Therefore, the assumption of a rigid arterial compartment 
can be considered to provide a ‘worst-case’ scenario for the 
influence of flow pulsations.
The present study used the build-in finger pulse-oxy 
triggering of the MRI-scanner to synchronize the end-of-
labeling with the cardiac cycle, which always lags behind 
in time compared to ECG-triggering. The present simula-
tions suggest that the optimal moment of triggering lies 
at the end-systolic phase, which corresponds to the finger 
pulse-oxy trigger with a delay of 0 ms. Although ECG trig-
gering would allow more flexibility in choosing end-of-
labeling phases within the systole, the practical application 
of finger triggering in the present study can be expected not 
to have influenced the accuracy (see Table 2) of the end-of-
labeling triggering.
Conclusions
In summary, simulations showed that flow pulsations can 
influence the ASL-signal by approximately 4%, and that 
especially the cardiac cycle at the end-of-labeling is of 
importance. However, in vivo experiments provided no dif-
ference in mean signal and/or signal stability. Combined 
with earlier findings concerning cardiac triggering, neither 
start-of-labeling nor end-of-labeling triggering improves 
signal stability significantly, suggesting that cardiac trig-
gering is not very beneficial for pCASL. Post-processing 
methods that include cardiac and/or other physiological 
regressors (including the timing at the end-of-labeling) 
could be considered to correct most of the remaining minor 
influences of the cardiac cycle on pCASL stability.
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